Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		81,259,676
Beginning balance at Dec. 31, 2022	$ 672,435	$ 8	$ 714,871	$ (42,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,058,804
Issuance of common stock upon exercise of stock options	9,475	$ 1	9,474
Issuance of common stock upon settlement of restricted stock units (in shares)		2,247,325
Shares withheld related to net share settlement of restricted stock units (in shares)		(375)
Shares withheld related to net share settlement of restricted stock units	(6)		(6)
Stock-based compensation expense	148,163		148,163
Issuance of common stock under employee stock purchase plan (in shares)		459,459
Issuance of common stock under employee stock purchase plan	8,431		8,431
Net loss	(197,734)			(197,734)
Ending balance (in shares) at Sep. 30, 2023		85,024,889
Ending balance at Sep. 30, 2023	640,764	$ 9	880,933	(240,178)
Beginning balance (in shares) at Jun. 30, 2023		83,811,484
Beginning balance at Jun. 30, 2023	638,145	$ 8	838,000	(199,863)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		288,111
Issuance of common stock upon exercise of stock options	2,803	$ 1	2,802
Issuance of common stock upon settlement of restricted stock units (in shares)		777,969
Stock-based compensation expense	37,428		37,428
Issuance of common stock under employee stock purchase plan (in shares)		147,325
Issuance of common stock under employee stock purchase plan	2,703		2,703
Net loss	(40,315)			(40,315)
Ending balance (in shares) at Sep. 30, 2023		85,024,889
Ending balance at Sep. 30, 2023	$ 640,764	$ 9	880,933	(240,178)
Beginning balance (in shares) at Dec. 31, 2023	86,330,303	86,330,303
Beginning balance at Dec. 31, 2023	$ 635,305	$ 9	917,872	(282,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,488,118	1,488,118
Issuance of common stock upon exercise of stock options	$ 12,281		12,281
Issuance of common stock upon settlement of restricted stock units (in shares)		2,846,811
Shares withheld related to net share settlement of restricted stock units (in shares)		(541)
Shares withheld related to net share settlement of restricted stock units	(19)		(19)
Stock-based compensation expense	106,413		106,413
Issuance of common stock under employee stock purchase plan (in shares)		333,564
Issuance of common stock under employee stock purchase plan	7,685		7,685
Purchase of capped calls	(40,883)		(40,883)
Settlement of capped calls	580		580
Net loss	$ (125,826)			(125,826)
Ending balance (in shares) at Sep. 30, 2024	90,998,255	90,998,255
Ending balance at Sep. 30, 2024	$ 595,536	$ 9	1,003,929	(408,402)
Beginning balance (in shares) at Jun. 30, 2024		89,084,180
Beginning balance at Jun. 30, 2024	594,710	$ 9	996,345	(401,644)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		867,016
Issuance of common stock upon exercise of stock options	10,062		10,062
Issuance of common stock upon settlement of restricted stock units (in shares)		912,103
Shares withheld related to net share settlement of restricted stock units (in shares)		(475)
Shares withheld related to net share settlement of restricted stock units	(17)		(17)
Stock-based compensation expense	34,722		34,722
Issuance of common stock under employee stock purchase plan (in shares)		135,431
Issuance of common stock under employee stock purchase plan	3,120		3,120
Purchase of capped calls	(40,883)		(40,883)
Settlement of capped calls	580		580
Net loss	$ (6,758)			(6,758)
Ending balance (in shares) at Sep. 30, 2024	90,998,255	90,998,255
Ending balance at Sep. 30, 2024	$ 595,536	$ 9	$ 1,003,929	$ (408,402)